Therefore, larger, longitudinal studies are needed to systematically evaluate the prognostic and therapeutic implications of chromothripsis and chromoplexy in CLL, particularly in the context of intact TP53. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.